Delta-8 THC and THC-O: How Federal Law and Safety Concerns Differ

Delta-8 THC is not simply a legal substitute for marijuana, and THC-O is not automatically covered by the same federal hemp exception. The two compounds differ chemically, pharmacologically and legally—and the rules are changing.

Is delta-8 THC legal?

As of August 30, 2026, federal law still defines hemp as cannabis and cannabis-derived products containing no more than 0.3% delta-9 THC by dry weight. The statute includes derivatives, extracts and cannabinoids, but it does not specifically mention delta-8 THC. The current definition is available in the U.S. Code.

That omission created the market for hemp-derived delta-8 products. Delta-8 occurs naturally in cannabis in very small amounts, so commercial products are commonly made by converting hemp-derived CBD into concentrated delta-8 THC.

In AK Futures LLC v. Boyd Street Distro LLC, a 2022 trademark case, the U.S. Court of Appeals for the Ninth Circuit held that the Farm Bill’s wording covered the company’s delta-8 products, assuming they contained no more than the legal limit of delta-9 THC. The ruling was important, but it was not a nationwide declaration that every delta-8 product is lawful. It also did not guarantee that products are accurately labeled or safely manufactured.

State law is a separate question. Some states prohibit delta-8 or regulate it through age limits, testing requirements, packaging rules or cannabis licensing systems. State policies also change, so consumers should check the rules in the state where a product is sold, possessed or used. The National Conference of State Legislatures’ cannabis legislation database provides a useful starting point for tracking enacted state laws.

How delta-8 differs from delta-9 THC

Delta-8 and delta-9 THC are closely related isomers: they have the same atoms arranged differently. Both can produce intoxicating effects, although delta-8 is generally described as less potent than delta-9. The strength and experience can vary substantially with the dose, route of administration, product formulation and individual response.

Delta-8 products should not be confused with non-intoxicating hemp products. The U.S. Food and Drug Administration says that delta-8 has psychoactive and intoxicating effects and that its products have not been evaluated or approved for safe use in any context.

What is THC-O?

THC-O usually refers to THC-O-acetate, an acetate ester made by chemically modifying delta-8 or delta-9 THC. Unlike delta-8, THC-O is not a cannabinoid found naturally in meaningful amounts in the cannabis plant. Claims that it is “three times stronger” or reliably psychedelic are not supported by good human clinical evidence.

A 2024 peer-reviewed study of THC-O-acetate users found limited evidence for the product’s reputation as a psychedelic. Participants generally reported cognitive changes but few visual effects or hallucinations, and 79% said the experience was “not at all” or only “a little” psychedelic. The study was based on an online survey, not a controlled clinical trial, so it cannot establish THC-O’s safety or precisely compare its potency with delta-8 or delta-9.

THC-O’s legal position is also different from delta-8’s. The Congressional Research Service summarizes the Drug Enforcement Administration’s position that THC-O does not qualify for the 2018 hemp exception because it is not naturally produced by the cannabis plant. Under that interpretation, THC-O remains subject to federal controlled-substance rules. The issue has also been affected by court decisions and changing legislation, so a product’s “hemp-derived” label is not, by itself, proof that the product is federally lawful.

The safety questions

Both delta-8 and THC-O products can present risks beyond the effects of THC itself. The FDA has received adverse-event reports involving delta-8 products, including cases involving vomiting, confusion, loss of consciousness, anxiety and hallucinations. The agency has also warned that manufacturing may leave behind reaction by-products, heavy metals, solvents or other contaminants—particularly when products are made without consistent laboratory testing.

Those concerns do not mean every delta-8 product is contaminated, but they do mean that potency and ingredient claims should be treated cautiously. A certificate of analysis is more useful when it identifies the testing laboratory, batch number, cannabinoid concentrations, residual solvents, pesticides, heavy metals and microbial contaminants. Even then, a laboratory report does not establish that a product is medically safe.

THC-O raises an additional concern when it is heated. Laboratory researchers have warned that acetate compounds may break down at high temperatures and produce ketene, a toxic gas. This is a chemical hazard signal, not proof that every THC-O vape causes lung injury. The 2019 EVALI outbreak was most strongly associated with vitamin E acetate in THC-containing vaping products, according to the Centers for Disease Control and Prevention; that evidence should not be presented as proof that THC-O itself caused the outbreak.

The federal rules are scheduled to tighten

Congress changed the federal definition of hemp in November 2025. The amendment is scheduled to take effect on November 12, 2026—365 days after enactment. It will use total THC, including THCA, rather than only delta-9 THC, and will exclude certain hemp-derived cannabinoid products containing synthetically made or highly intoxicating cannabinoids. A Congressional Research Service analysis explains the changes and their potential effect on delta-8, THC-O and similar products.

Until that amendment takes effect, the federal status of delta-8 remains tied largely to the existing delta-9 THC-based definition of hemp, while state restrictions and other federal laws—including rules governing food, drugs, labeling and therapeutic claims—may still apply. After November 12, 2026, many products currently sold as hemp-derived intoxicating cannabinoids may no longer meet the federal definition of hemp.

For consumers, the practical lesson is straightforward: delta-8 is intoxicating and may be restricted where you live; THC-O has less safety and human pharmacology data and a more difficult federal legal position; and neither product should be treated as an FDA-approved medicine. People who experience severe symptoms after using a cannabinoid product should seek medical care or contact Poison Control at 1-800-222-1222.